septemb
million
pilgrim
contin
arriv
saudi
arabia
annual
hajj
pilgrimag
live
worship
togeth
crowd
condit
expos
pilgrim
local
saudi
arabian
commun
rang
import
local
infect
past
year
hajj
focus
attent
new
reemerg
infecti
diseas
epidem
potenti
middl
east
respiratori
syndrom
coronaviru
merscov
zika
viru
panantibioticresist
bacteriaglob
health
secur
threat
ongo
activ
surveil
year
explos
outbreak
cholera
yemen
mani
pilgrim
origin
repres
seriou
risk
pilgrim
hajj
potenti
global
spread
pilgrim
return
countri
origin
juli
publish
onlin
august
http
cholera
epidem
yemen
affect
estim
peopl
caus
death
new
activ
case
report
everi
day
cholera
hajj
new
hajj
pilgrim
die
result
global
cholera
epidem
start
india
spread
across
world
anoth
cholera
epidem
hajj
kill
pilgrim
spread
worldwid
includ
usa
europ
death
deal
infecti
diseas
outbreak
outbreak
prevent
hajj
public
health
prioriti
saudi
arabia
repeat
endem
outbreak
diarrhoeal
diseas
occur
result
variou
pathogen
preval
countri
pilgrim
origin
sinc
outbreak
saudi
arabian
health
author
well
prepar
respond
outbreak
major
cholera
outbreak
larg
improv
infrastructur
surveil
rapid
detect
control
hajj
command
control
centr
ensur
hygien
live
condit
pilgrim
easi
free
access
wash
facil
purifi
water
health
servic
latest
overal
cholera
preval
yemen
estim
per
popul
yemeni
obtain
visa
hajj
attack
rate
similar
number
yemeni
pilgrim
plan
attend
hajj
roughli
case
cholera
expect
notabl
individu
infect
vibrio
cholera
show
symptom
remain
undetect
infecti
thu
cholera
pose
substanti
public
health
challeng
hajj
ongo
cholera
epidem
yemen
call
extrem
caution
requir
particular
attent
given
prevent
surveil
control
measur
advanc
develop
assess
new
cholera
vaccin
provid
hope
better
control
strateg
advisori
group
expert
sage
immunis
conclud
meet
april
mount
evid
past
year
high
coverag
oral
cholera
vaccin
ocv
result
signific
reduct
cholera
transmiss
variou
set
three
kill
wholecel
ocv
prequalifi
whodukor
valneva
stockholm
sweden
shanchol
shantha
biotechn
hyderabad
india
euvichol
eubiolog
seoul
south
korea
three
vaccin
good
safeti
profil
greater
effect
cholera
diseas
least
year
two
dose
formal
establish
ocv
stockpil
consist
shanchol
euvichol
thu
mandat
cholera
vaccin
pilgrim
yemen
countri
cholera
endem
might
prudent
requir
practic
feasibl
recommend
saudi
arabia
jointli
commiss
risk
assess
review
potenti
benefit
risk
cost
practic
cholera
vaccin
come
feasibl
recommend
oper
clinic
financi
polit
sustain
recommend
includ
saudi
arabian
health
requir
pilgrim
furthermor
guidelin
measur
prevent
cholera
commun
awar
campaign
put
practic
strictli
implement
proactiv
health
educ
campaign
implement
hajj
use
leaflet
social
media
target
pilgrim
local
saudi
arabia
popul
requir
campaign
includ
recommend
basic
hygien
toilet
practic
includ
handwash
defec
handl
food
eat
healthseek
behaviour
develop
symptom
meanwhil
focu
cholera
must
deter
saudi
arabian
author
remain
vigil
regard
epidemicpron
gastrointestin
respiratori
tract
pathogen
percentag
also
chang
second
sentenc
discuss
figur
correct
reflect
new
data
third
sentenc
result
main
text
absolut
increas
consumpt
chang
cephalosporin
standard
unit
broadspectrum
penicillin
standard
unit
fourth
sentenc
rel
increas
correct
monobactam
glycopeptid
cephalosporin
fluoroquinolon
fourth
sentenc
second
paragraph
result
follow
text
remov
two
except
consumpt
increas
substanti
australia
unit
per
person
new
zealand
unit
per
person
note
continu
increas
antibiot
consumpt
sixth
sentenc
paragraph
follow
text
remov
highincom
asian
countri
region
hong
kong
malaysia
singapor
south
korea
rank
within
top
eight
consum
antibiot
per
person
paragraph
percentag
increas
global
antibiot
consumpt
attribut
bric
countri
chang
fifth
sentenc
discuss
word
chang
moder
read
also
note
moderatelyhigh
antibiot
consumpt
per
person
australia
new
zealand
follow
sentenc
remov
sinc
longer
reflect
data
nation
campaign
implement
reduc
inappropri
use
antibiot
upper
respiratori
tract
infect
start
campaign
led
decreas
number
antibiot
prescript
upper
respiratori
tract
infect
reason
continu
high
antibiot
use
clear
howev
nausp
data
consumpt
hospit
indic
decreas
use
antibiot
new
zealand
recent
studi
investig
nationwid
antibiot
use
commun
year
period
antibiot
consumpt
rate
per
person
high
compar
mani
european
countri
continu
rise
averag
per
year
consist
studi
find
unabl
find
nationwid
hospit
antibiot
consumpt
inform
one
hospit
studi
observ
lower
consumpt
compar
mani
european
countri
australia
nation
campaign
new
zealand
associ
decreas
antibiot
prescript
upper
respiratori
tract
infect
among
children
howev
reason
high
consumpt
unclear
third
